#medical-devices

#medical-devices

Pulse oximeters show racial bias, with readings less reliable for Black patients, leading to delayed treatments and worsening health outcomes.

Nearly half of the world's exposed medical devices are located in the U.S., highlighting significant cybersecurity vulnerabilities in the healthcare sector.

The European Commission's Action Plan seeks to enhance cybersecurity in the healthcare sector in response to rising cyber threats.

The Action Plan addresses interdependencies within the healthcare ecosystem, impacting not just providers but also pharmaceutical and medical device industries.

A possible trade war could severely impact Canada's health care system through increased costs and disruption of medical device supplies.

Philips is focusing on healthcare innovations and leveraging AI to redefine its business model for the future.

Neeraj Mainkar highlights the importance of safety and effectiveness in developing medical devices, marking innovation's crucial role in healthcare.

Trump administration's layoffs at HHS raise concerns over medical device cybersecurity efforts during congressional hearings.

FDA approved Humacyte's lab-grown blood vessels despite serious patient complications, raising concerns about study validation and patient safety.

The FDA proposes extra data requirements for pulse oximeter efficacy in patients of color due to racial biases in medical technology.

Dr. Jeffrey E. Shuren's FDA career was marked by both record device approvals and significant ethical concerns due to his industry's connections.

Combining related functions in product design can enhance user experience without overwhelming them.

The Nurosym vagus nerve stimulation device may significantly enhance short-term memory and provide a range of health benefits by stimulating the vagus nerve.

Level Zero Health aims to develop a continuous hormone monitoring device, potentially transforming hormone health similar to CGMs for diabetes.

Frida Baby's new Electric NoseFrida Pro offers powerful, automatic snot extraction for infants, addressing congestion more effectively than previous versions.

Symphera has raised €2.4M in seed funding to develop surgical systems that automate tool-switching in laparoscopic procedures.

Robotic-assisted surgery is revolutionizing surgical approaches by enabling minimally invasive procedures that improve patient outcomes.

Validated DevOps revolutionizes medical device development by aligning speed and compliance, enhancing safety and innovation in healthcare.

The developed robotic finger enhances early detection of breast cancer and improves patient comfort during examinations.

CeQur raised $120M to expand its commercial operations and enhance its insulin delivery technology for diabetes care.

A proactive approach and innovative technology are key to improving health monitoring and patient care.

Groundbreaking medical innovations like wearable devices and adaptive casts are reshaping healthcare delivery.

Innovative nerve stimulation device for sleep apnoea offers patients a new treatment option in the UK.

The case underscores the complexity of trademark functionality doctrine in the medical device industry, particularly regarding product coloration and patent-exhaustion.

Minerva Surgical's patents may reveal prior knowledge of significant safety issues with its devices, raising questions of accountability in product claims.

Boston Scientific has successfully recovered and transformed from past failures through strategic acquisitions and effective leadership, culminating in a $130 billion valuation.

Royal Philips emphasized patient safety post-recall by establishing a new C-suite role and fostering a culture of openness and responsibility.

Neuralink's Blindsight implant has been approved to assist blind patients, even those blind from birth, in regaining their sight.

The GyroGlove is a groundbreaking device for stabilizing hands affected by essential tremors, significantly improving users' quality of life.